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article under the CC BY-NC-ND licenseAbstract Objective: Five to ten percent of interstitial cystitis/bladder pain syndrome
(IC/BPS) patients have Hunner’s lesions (HL), areas of non-specific inflammation and scarring.
The poor quality of life of patients with HL is entwined in associated pain and loss of bladder
capacity. Although the decrease in bladder capacity is usually dependent on pain, it may also
be dependent upon scarring and associated compliance changes produced by the inflammatory
process. This report reviews the potential role of endoscopic scar lysis using the holmium laser
in the management of these patients whose only other therapeutic option is urinary diversion.
Methods: Two patients with HL and “end stage” bladders who underwent holmium laser divi-
sion of bladder wall scar/tethering were identified. Clinical data were reviewed with emphasis
on safety and efficacy.
Results: Both patients selected for this procedure underwent holmium laser lysis of known scar
tissue in an effort to increase bladder capacity and improve symptoms of urinary frequency
and pain with bladder filling. The median age of patients who underwent the procedure was
63 (59e67) years. Incisions were made with the holmium laser at frequencies of 3e10 Hz of
300e700 J along the region of scarring. All procedures were performed by the same practi-
tioner. There was an increase in bladder capacity by 58.3% (50.0%e66.7%). During a mean
follow-up of 4.2 years, there appeared to be a significant improvement with an increase in in-
terval time between voids and a decrease in pain with bladder filling.
Conclusion: Patients with IC/BPS may be severely debilitated by a clinically significant
decrease in their bladder capacity, especially in the face of HL. The use of the holmium laser
to incise regions of scar and bladder wall tethering may produce a clinically significant and du-
rable increase in bladder capacity. The use of this technique as a means of treating bladder
scarring poses an excellent adjunct to existing treatment strategies.
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Interstitial cystitis/bladder pain syndrome (IC/BPS) is a
chronic, often disabling condition characterized by bladder
pain, urinary frequency, and urgency. Five to ten percent of
patients with IC/BPS have Hunner’s lesions (HL), regions of
transmural inflammation appearing as patches of reddened
mucosa, often associated with small vessels radiating from
a central pale scar [1]. These areas of inflammation and
scarring usually result in the severe symptoms typically
described in this patient population. The HL are thought to
be the cause of pain; however, the associated scarring of
the bladder appears, in many instances, to be associated
with tethering of the bladder wall and changes in bladder
capacity and compliance [2]. Furthermore, although
fulguration of HL is a recommended therapy, concern has
been raised that these procedures, while improving pain,
may be associated with increased bladder wall scarring [3].
Ultimately, some IC/BPS patients with HL develop an
“end stage” bladder on the basis of bladder wall fibrosis;
with the only further option of care being urinary diversion.
This highlights the need for a treatment strategy aimed at
increasing bladder capacity while having low potential to
create further bladder wall scarring. The holmium laser may
be able to provide such benefits in patients with HL. The use
of holmium laser as a means of therapy has been widely
used in the field of urology [4]. To date, however, there
have been no published reports on the use of this form of
energy to treat the bladder wall changes seen in this select
group of patients. The following report will explore two
cases in which the holmium laser was used to incise bladder
wall scar, thereby improving bladder capacity.
2. Cases
A chart review of two patients with IC/BPS and known scar
formation were identified. Operative reports from cystos-
copy and use of holmium laser were reviewed.
In both cases the holmium laser was used at 3e10 Hz and
300e700 J during cystoscopic visualization under general
anesthesia. Postoperative follow-up was recommendedFigure 1 Bladder scar wwithin 2 weeks of the procedure. Routine follow-up was
arranged at 3, 6, and 12-month intervals. Symptomatic data
on clinical improvement during follow-up visits were ob-
tained with medical record review. Data on follow-up were
obtained over a period of 4.2 years.
2.1. Descriptions of case No. 1
A 66-year-old female with a history of IC/BPS complicated
by multiple HL presented in consultation for increasing
bladder pain and frequency. Office cystoscopy demon-
strated extensive bladder wall scarring and mucosal teth-
ering. Filling produced severe pain at approximately 30 mL.
The patient had previously failed multiple medical and
intravesical therapies and was otherwise a candidate for
urinary diversion. Unfortunately, the use of bowel for
reconstruction was limited due to her history of Crohn’s
disease with high grade stricture of distal ileum and a sta-
ble enteroeentero fistula. The patient had undergone prior
cystoscopic procedures with fulguration of HL, injection of
triamcinolone into areas of scarring, and hydrodistention.
In an attempt to increase her bladder capacity and manage
pain, the patient selected to proceed with endoscopic lysis
of her bladder scar. Preoperative CT scan showed no sug-
gestion of an enterovesical fistula. No bowel was identified
adjacent to the region of scar. The patient was counseled
on the possibility of intraperitoneal rupture and the need
for post operative foley catheterization.
Intraoperatively, scar and mucosal tethering originating
along the right posterior mid lateral wall was identified. The
bladder underwent distention with normal saline to approxi-
mately 60 cm H2O in order to facilitate separation of the scar
as the incision was deepened. Using a 550 mm fiber, three in-
cisions were created with the holmium laser at frequencies of
3e10 Hz and 300e400 J along the region of scarring down to
perivesical fat. Minimal bleeding was encountered through
the scarred regions (Fig. 1).AFoleycatheterwas left in situ for
1 week. Subsequent cystogram showed no extravasation. The
patient was instructed to proceed with a bladder retraining
(holding) protocol in order to maintain her bladder capacity.
During immediate follow-up, the patient reported
improvement in her urinary frequency. She found anith mucosal tethering.
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decrease in pain with bladder filling. During cystoscopy
approximately 2 years later there appeared to be continued
bladder scarring in the posterior right mid lateral wall;
however, distinct areas of normal bladder mucosa in this
region were also noted. The patient tolerated bladder
filling to approximately 60 mL.
2.2. Descriptions of case No. 2
A 59-year-old female with a history of IC/BPS presented in
consultation for bladder pain and increased urinary fre-
quency. During the patient’s clinical evaluation she un-
derwent cystoscopy which demonstrated HL with multiple
areas of scar and mucosal tethering. Her bladder capacity
during in-office cystoscopy was 120 mL. She had undergone
prior cystoscopic procedures with fulguration of HL, injec-
tion of triamcinolone into areas of scarring, and hydro-
distention without improvement of her symptoms. The
patient’s past surgical history was significant for multiple
abdominal hernia repairs, hysterectomy, and removal
gangrenous large bowel. Preoperative CT scan showed no
abnormalities. The patient subsequently underwent
cystoscopy where a large area of banding scar was identi-
fied along the right posterior bladder wall. This area was
divided in several regions with a holmium laser using fre-
quencies of 3e10 Hz and 700 J during slow hydrodistention
of the bladder to approximately 60 cmH2O. A 550 mm fiber
was used for this procedure (Fig. 2). A Foley catheter was
left in situ for 1 week. Subsequent cystogram showed no
extravesical extravasation. As with patient in the first case,
she was asked to proceed with a bladder holding protocol.
During immediate follow-up, the patient reported
improvement in her urinary frequency. Her pain with bladder
filling appeared to improve (from 8/10 on pain scale to 5/10)
per patient report. Repeat in-office cystoscopy approximately
2 years later still revealed significant posterior bladder wall
scarring with tethering; however, her bladder capacity at this
time was increased to 200 mL through in-office cystoscopy.
3. Discussion
The use of the holmium laser to improve the bladder ca-
pacity of those patients with severe bladder wall scarring is
a novel technique that has not previously been explored.Figure 2 Incision of bladder scar with holmiumThe two IC/BPS patients presented suffered from severe
bladder wall fibrosis, mucosal tethering, and loss of bladder
capacity [5,6]. Both had failed previous conservative man-
agement, endoscopic ablative procedures, and steroid in-
jections to their HL. Although each was a candidate for
urinary diversion, this procedure produced a relatively
large increase in bladder capacity and, most importantly,
had a favorable impact on their quality of life. These clin-
ical benefits appear to be secondary to a notable increase
in bladder capacity after the procedure.
The etiology of decreased bladder compliance and ca-
pacity in patients with HL can be attributed to bladder pain
and bladder wall scarring [7,8]. In this instance, improve-
ment in bladder capacity is based upon small increases in
the bladder’s radius producing a profound effect on its
volume through the simple relationship VZ 4/3 pr3. Thus,
a 50 mL bladder capacity can be doubled through a 0.6 cm
increase in its radius. This effect was clinically evident with
a mean increase in bladder capacity after the use of the
holmium laser by 58.3% (50.0%e66.7%) (Fig. 3).
The holmium laser for management of endoscopic scar
lysis in patients with HL was chosen because of its theo-
retical ability to minimize further bladder scarring in a
patient with a preexisting marked reduction in bladder
capacity. Indeed, the holmium laser is commonly used in
the endoscopic management of urethral stricture disease
[9] and when employed for treatment of urethral carci-
noma, was associated with a stricture rate of less than 9%
[10e12]. In addition, the necessity for tissue contact, the
small fiber size, and its average depth of tissue penetration
of 0.5 mm allows for the incisions to be performed with
precision and with little surrounding tissue trauma [10]. We
found slow hydrodistention with saline to be helpful during
the procedure to separate the tissue as the incision was
elongated. In both patients, scar traversed the entire
bladder wall and incisions needed to be carried down to
perivesical fat (Figs. 1 and 2). Care should be taken to limit
operative time particularly when there is concern for
extravesical fluid extravasation. Patients should be coun-
seled about the possibility of intraperitoneal extravasation,
particularly when dividing dome lesions.
The median interval time between cystoscopic pro-
cedures that were performed in office to determine
bladder capacity was 2.2 years. During a mean follow-up of
4.2 years, there appeared to be a significant increase inlaser. Note the exposure of perivesical fat.
Figure 3 Increase in bladder capacity after holmium laser division of scar tissue.
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filling. However, these improvements were most pro-
nounced during the first 3e6 months after the procedure. In
order to prevent or delay the redevelopment of scar, we
have stressed the need for a post operative bladder holding
protocol where the patient is asked to defer daytime
voiding approximately 15e20 min beyond their normal
sensation of fullness.
While it is clear that patients must still undergo strict
bladder retraining protocols, this treatment may prove to
be an excellent adjunct to triamcinolone injections and
fulguration of these lesions. While this report documents
two such cases, future studies aimed at a larger population
size in addition to further prospective studies will allow for
further characterization of this technique as a means of
treatment and may have applicability to other conditions
where severe bladder wall fibrosis also poses an issue.
4. Conclusion
The two presented cases demonstrate the use of holmium
laser to divide scar tissue and thereby increase bladder
capacity by more than 50.0%, ultimately improving symp-
toms associated with IC/BPS. The effects of the procedure
were most pronounced 3e6 months after therapy with both
patients reporting an increase in interval time between
voids and a decrease in pain with bladder filling. The use of
the holmium laser is an innovative technique for treating
bladder scarring that poses an excellent adjunct to existing
treatment strategies in patients with IC/BPS.
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